<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03531853</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00092968</org_study_id>
    <nct_id>NCT03531853</nct_id>
  </id_info>
  <brief_title>OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers</brief_title>
  <official_title>OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and demonstrate new technologies that will enable a&#xD;
      non-contact, compact eye imaging system based on OCT to assist an early responder in acute&#xD;
      care settings (like an emergency room) to help assess eye trauma and inflammation (swelling&#xD;
      inside the eye).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance</measure>
    <time_frame>Up to 18 months</time_frame>
    <description>By the ability to detect cells in the eye compared to clinical exam</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>Imaging patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Get uveitis patients and ER patients to image their eyes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hand-held swept source optical coherence tomography</intervention_name>
    <description>images the eye</description>
    <arm_group_label>Imaging patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Pre-clinical: employees or students (over the age of 18) of the Duke Eye Center or&#xD;
        Biomedical Engineering willing to be imaged with OCT system&#xD;
&#xD;
        - Pilot (ER): patients (over the age of 18) presenting emergently to the Duke Emergency&#xD;
        room with traumatic eye injuries and/or suspected open globe&#xD;
&#xD;
        - Pilot (Uveitis): patients presenting to the Duke Eye Center with active uveitis and&#xD;
        microhyphema or hyphema; patients who have independently consented to undergo vitreous tap&#xD;
        or biopsy for their uveitis care at the Duke Eye Center&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Pre-clinical: subject cannot be a direct report to any of the PIs or other key personnel&#xD;
        of this study&#xD;
&#xD;
        - Pilot (ER): hemodynamically unstable, unable to consent&#xD;
&#xD;
        - Pilot (Uveitis): unable to consent; cornea or lens opacity/scar which would block the&#xD;
        imaging modality&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Kuo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teresa Hawks</last_name>
    <phone>919-681-1569</phone>
    <email>teresa.hawks@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Hawks</last_name>
      <phone>919-681-1569</phone>
      <email>teresa.hawks@duke.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

